Inactivated SARS-CoV-2 vaccine FAKHRAVAC (Organization of Defensive Innovation and Research)

N/A

Report date: 2022/05/16 14:05:11

Base Information

Drug NameInactivated SARS-CoV-2 vaccine FAKHRAVAC (Organization of Defensive Innovation and Research)
Drug Alias NameMIVACFAKHRAVAC
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIran
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrganization of Defensive Innovation and Research
China Registration ClassN/A

Develop Information

Active CompaniesOrganization of Defensive Innovation and Research
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A